We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
-1.98%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$2.85B
AUM Growth
+$102M
Cap. Flow
+$208M
Cap. Flow %
7.28%
Top 10 Hldgs %
21.68%
Holding
535
New
168
Increased
71
Reduced
85
Closed
189

Top Buys

Rank Stock Value
1
SN icon
SharkNinja
SN
+$75.8M
2
DIS icon
Walt Disney
DIS
+$62.3M
3
KVUE icon
Kenvue
KVUE
+$55.7M
4
TGT icon
Target
TGT
+$51.2M
5
SMH icon
VanEck Semiconductor ETF
SMH
+$38.5M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$47.9M
2
VFC icon
VF Corp
VFC
+$40.9M
3
SPLK
Splunk Inc
SPLK
+$36.3M
4
BA icon
Boeing
BA
+$30.1M
5
JNJ icon
Johnson & Johnson
JNJ
+$26.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.36%
2 Technology 13.19%
3 Healthcare 9.24%
4 Industrials 8.98%
5 Communication Services 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABOS icon
351
Acumen Pharmaceuticals
ABOS
$157M
-62,986
Closed -$303K
ABNB icon
352
PUT
Airbnb
ABNB
$89.4B
-54,700
Closed -$7.01M
ACAD icon
353
PUT
Acadia Pharmaceuticals
ACAD
$4.39B
-27,000
Closed -$647K
ACI icon
354
Albertsons Companies
ACI
$5.58B
-301,262
Closed -$6.57M
ACN icon
355
Accenture
ACN
$104B
-1,191
Closed -$368K
AFRM icon
356
CALL
Affirm
AFRM
$26.2B
-149,200
Closed -$2.29M
AFRM icon
357
Affirm
AFRM
$26.2B
-702,205
Closed -$10.8M
AKAM icon
358
Akamai
AKAM
$17.9B
-17,783
Closed -$1.6M
ALDX icon
359
PUT
Aldeyra Therapeutics
ALDX
$92.3M
-108,000
Closed -$906K
AMTX icon
360
Aemetis
AMTX
$107M
-80,256
Closed -$588K
AMZN icon
361
CALL
Amazon
AMZN
$2.99T
-52,500
Closed -$6.84M
ANF icon
362
Abercrombie & Fitch
ANF
$4.84B
-83,068
Closed -$3.13M
APLS
363
DELISTED
Apellis Pharmaceuticals
APLS
-8,476
Closed -$372K
APLS
364
PUT
DELISTED
Apellis Pharmaceuticals
APLS
-13,500
Closed -$1.23M
ARVN icon
365
CALL
Arvinas
ARVN
$520M
-6,800
Closed -$169K
AVDL
366
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
-108,000
Closed -$1.78M
AVT icon
367
Avnet
AVT
$7.59B
-99,087
Closed -$5M
BA icon
368
Boeing
BA
$187B
-142,588
Closed -$30.1M
BARK icon
369
BARK
BARK
$88.8M
-141,155
Closed -$3.75M
BC icon
370
PUT
Brunswick
BC
$5.16B
-33,800
Closed -$2.93M
BIDU icon
371
CALL
Baidu
BIDU
$38.2B
-3,000
Closed -$411K
BJ icon
372
BJs Wholesale Club
BJ
$12.4B
-257,619
Closed -$16.2M
BKNG icon
373
Booking.com
BKNG
$151B
-2,075
Closed -$224K
BMRN icon
374
PUT
BioMarin Pharmaceuticals
BMRN
$11.6B
-17,500
Closed -$1.52M
BMY icon
375
PUT
Bristol-Myers Squibb
BMY
$135B
-17,500
Closed -$1.12M

Similar funds

J. Goldman & Co's Q3 2023 Portfolio in Review

As of Q3 2023, J. Goldman & Co held 535 positions worth $2.85B, up 3.7% from $2.75B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

J. Goldman & Co deployed $208M of net new capital in Q3 2023, opening 168 new positions and adding to 71 existing holdings. Its largest new stake was SharkNinja: 2,071,888 shares worth $96.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $47.9M trimmed.

  • J. Goldman & Co's largest Q3 2023 buy was SharkNinja: 2,071,888 shares worth $96.1M.
  • J. Goldman & Co added most to PayPal in Q3 2023, an estimated $34.3M increase.
  • J. Goldman & Co's biggest Q3 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $47.9M.
  • J. Goldman & Co fully exited VF Corp in Q3 2023, selling an estimated $40.9M.
  • J. Goldman & Co's ten largest holdings make up 22% of its $2.85B portfolio in Q3 2023.
  • J. Goldman & Co opened 168 new positions and closed 189 in Q3 2023.
  • J. Goldman & Co's portfolio value rose 3.7% quarter-over-quarter to $2.85B.

Based on J. Goldman & Co's 13F filing for Q3 2023, filed 14 Nov 2023.